The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition

Journal of Surgical Research

Volumn 178, Issue 1, 2012, Pages 33-39

  Gaitonde, Shrawan ^a   Kohli, Rohit ^b   Seeley, Randy ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Bariatric surgery; Diabetes; Exendin 9 39; Glucagon like peptide 1 (GLP 1); Glucose homeostasis; Glucose regulation; Hindgut hypothesis; Ileal transposition; Roux en Y gastric bypass (RYGB)

Indexed keywords

EXENDIN 9 39; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HORMONE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BARIATRIC SURGERY; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; FOOD INTAKE; GLUCOSE HOMEOSTASIS; HORMONE RELEASE; ILEAL TRANSPOSITION; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; STOMACH TRANSPOSITION;

ANIMALS; BARIATRIC SURGERY; BODY COMPOSITION; BODY WEIGHT; EATING; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; ILEUM; JEJUNUM; MALE; OBESITY; RANDOM ALLOCATION; RATS; RATS, LONG-EVANS; SIGNAL TRANSDUCTION;

EID: 84868192541     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.04.044     Document Type: Article

References (35)

1. D.W. Haslam, and W.P. James Obestiy Lancet 366 2005 1197
2. F.X. Pi-Sunyer Comorbidities of overweight and obesity: Current evidence and research issues Med Sci Sports Exerc 31 11 Suppl 1999 S602
3. P.W. Sullivan, E.H. Morrato, V. Ghushchyan, H.R. Wyatt, and J. Hill Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002 Diabetes Care 28 2005 1599
4. M.J. McNeely, and E.J. Boyko Diabetes-related comorbidities in Asian Americans: Results of a national health survey J Diabetes Complications 19 2005 101
5. S.L. Maddigan, D.H. Feeny, and J.A. Johnson Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Survey Qual Life Res 14 2005 1311
6. W.J. Pories, M.S. Swanson, and K.G. MacDonald Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Ann Surg 222 1995 339
7. M.A. Makary, J.M. Clarke, and A.D. Shore Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery Arch Surg 145 2010 726
8. M.L. Nightengale, M.G. Sarr, and K.A. Kelly Prospective evaluation of vertical banded gastroplasty as the primary operation for morbid obesity Mayo Clin Proc 67 1991 304
9. L. Howard, M. Malone, and A. Michalek Gastric bypass and vertical banded gastroplasty - a prospective randomized comparison and 5-year follow-up Obes Surg 5 1995 55
10. E.A. Odstrcil, J.G. Martinez, and C.A. Santa Ana The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass Am J Clin Nutr 92 2010 704
11. J.M. Kellum, J.F. Kuemmerle, and T.M. O'Dorisio Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty Ann Surg 211 1990 763
12. F. Rubino, M. Gagner, and P. Gentileschi The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism Ann Surg 240 2004 236
13. A.D. Strader, T.P. Vahl, and R.J. Jandacek Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats Am J Physiol Endocrinol Metab 288 2005 E447
14. J.J. Holst Glucagon-like peptide 1 (GLP-1): An intestinal hormone, signaling nutritional abundance, with an unusual therapeutic potential Trends Endocrinol Metab 10 1999 229
15. H.S. Koopmans, and A. Sclafani Control of body weight by lower gut signals Int J Obes 5 1981 491
16. E.E. Mason Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery Obes Surg 9 1999 223
17. R. Kohli, M. Kirby, and K.D. Setchell Intestinal adaptation after ileal transposition surgery increases bile acid recycling and protects against obesity-related comorbidities Am J Physiol Gastrointest Liver Physiol 299 2010 G652 Epub
18. H. Buchwald, Y. Avidor, and E. Brawnwald Bariatric surgery: A systematic review and meta-analysis JAMA 292 2004 1724
19. P.R. Schauer, B. Burguera, and S. Ikramuddin Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus Ann Surg 238 2003 467
20. J.H. Sugarman, L.G. Wolfe, and D.A. Sica Diabetes and hypertension in sever obesity and effects of gastric bypass induced weight loss Ann Surg 237 2003 571
21. B.P. Bullock, R.S. Heller, and J.F. Habener Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor Endocrinology 137 1996 2968
22. N. Imeryuz, B.C. Yegen, and A. Bozkurt Glucagon-like peptide-1 inhibitis gastric emptying via vagal afferent-mediated central mechanisms Am J Physiol 237 4 Pt 1 1997 G920
23. M.E. Patti, S.M. Houten, and A.C. Bianco Serum bile acids are higher in humans with prior gastric bypass: Potential contribution to improved glucose and lipid metabolism Obesity 17 2009 1671
24. A. Chawla, J.J. Repa, and R.M. Evans Nuclear receptors and lipid physiology: Opening the X-files Science 294 2001 1866
25. S. Lee, K.G. Sahagian, and J.P. Schriver Relationship between varying Roux limb lengths and weight loss in gastric bypass Curr Surg 63 2006 259
26. J.J. Gleysteen Five-year outcome with gastric bypass: Roux limb length makes a diference Surg Obes Relat Dis 5 2009 242
27. J.G. Kral Malabsorptive procedures in surgical treatment of morbid obesity Gastroenterol Clin North Am 1987 293
28. C. Thomas, A. Gioiello, and L. Noriega TGR5-mediated bile acids sensing controls glucose homeostasis Cell Metab 10 2009 167
29. F. Rubino, A. Forgione, and D.E. Cummings The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes Ann Surg 244 2006 741
30. F.K. Knop Resolution of type 2 diabetes following gastric bypass surgery: Involvement of gut-derived glucagon and glucagonotropic signaling? Diabetologia 52 2009 2270
31. C.M. Edwards, I.F. Todd, and M. Mahrnoudi Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: Studies with the antagonist exendin 9-3 9 Diabetes 48 1999 86
32. P. Corrodi, P.A. Wideman, and V.L. Sutter Bacterial flora of the small bowel before and after bypass procedure for morbid obesity J Infect Dis 137 1978 1
33. P.D. Cani, N.M. Delzenne, and J. Amar Role of gut microflora in the development of obesity and insulin resistance following high-fat feeding Pathol Biol. 56 2008 305
34. J.L. Leyba, S.N. Aulestia, and S.N. Llopis Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of morbid obesity: A prospective study of 117 patients Obes Surg 2010 Epub
35. X. Shi, S. Karmali, and A.M. Sharma A review of laparoscopic sleeve gastrectomy for morbid obesity Obes Surg 20 2010 1171